THE CELLULAR AND MOLECULAR MECHANISMS OF DIABETIC COMPLICATIONS

George L. King(Joslin Diabetes Center), Michael Brownlee(Albert Einstein College of Medicine)

Endocrinology and Metabolism Clinics of North America

June 1, 1996

10.1016/s0889-8529(05)70324-8

Cited by 291

Related Papers

Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders

|New England Journal of Medicine|1994|3.8k

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.

|Proceedings of the National Academy of Sciences|1995|1.3k

Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor

|Science|1996|1.1k

Retinopathy in Diabetes

|Diabetes Care|2004|1.1k

Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications

|Circulation Research|2010|979